Risk for contrast nephropathy in patients undergoing coronarography

Artificial Organs

Volumn 34, Issue 6, 2010, Pages

  Manna, Gaetano La ^a   Pancaldi, Leonardo Goffredo ^b   Capecchi, Alessandro ^b   Maska, Edlira ^a   Comai, Giorgia ^a   Cappuccilli, Maria L ^a   Carretta, Elisa ^a   Lombardi, Alessandro ^a   Colì, Luigi ^a   Stefoni, Sergio ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b Ospedale di Bentivoglio   (Italy)

Author keywords

Acute renal failure; Cardiology; Continuous venovenous hemofiltration; Contrast media; Contrast media induced nephropathy; Coronarography; Periprocedural hydration; Risk factors

Indexed keywords

CONTRAST MEDIA; INTENSIVE CARE UNITS;

ACUTE RENAL FAILURE; CONTINUOUS VENOVENOUS HEMOFILTRATION; CONTRAST MEDIUM; CONTRAST MEDIUM-INDUCED NEPHROPATHY; HEMOFILTRATION; NEPHROPATHY; PERIPROCEDURAL HYDRATION; RENAL FAILURE; RISK FACTORS;

CARDIOLOGY;

ACETYLCYSTEINE; CREATININE; FUROSEMIDE; NONIONIC CONTRAST MEDIUM; SODIUM; CONTRAST MEDIUM;

ACUTE HEART INFARCTION; ADULT; AGE DISTRIBUTION; AGED; ALBUMIN BLOOD LEVEL; ANEMIA; ANGIOCARDIOGRAPHY; AORTA STENOSIS; AORTA VALVE REGURGITATION; ARTICLE; CIGARETTE SMOKING; CONTRAST INDUCED NEPHROPATHY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIURETIC THERAPY; FEMALE; FLUID INTAKE; GLOMERULUS FILTRATION RATE; HEART EJECTION FRACTION; HEART INFARCTION; HEART VENTRICLE FAILURE; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPERURICEMIA; HYPOTENSION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REGURGITATION; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SEX DIFFERENCE; SODIUM BLOOD LEVEL; CHEMICALLY INDUCED; KIDNEY DISEASES; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CONTRAST MEDIA; CORONARY ANGIOGRAPHY; FEMALE; HUMANS; KIDNEY DISEASES; MALE; RISK FACTORS;

EID: 77953190729     PISSN: 0160564X     EISSN: 15251594     Source Type: Journal    
DOI: 10.1111/j.1525-1594.2009.00984.x     Document Type: Article

References (25)

1. Parfey PS, Griffiths SM, Barrett BJ, et al. Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled study. N Engl J Med 1989 320 : 143 149.
2. Toprak O, Cirit M. Risk factors and therapy strategies for contrast-induced nephropathy. Ren Fail 2006 67 : 335 343.
3. McCullough PA, Adam A, Becker CR, Davidson C, Lameire N, Stacul F. Epidemiology and prognostic implications of contrast-induced nephropathy. Am J Cardiol 2006 98 : 5K 13K.
4. McCullough PA. Contrast-induced acute kidney injury. J Am Coll Cardiol 2008 51 : 1419 1428.
5. Rudnick M, Feldman H. Contrast-induced nephropathy: what are the true clinical consequences? Clin J Am Soc Nephrol 2008 3 : 263 272.
6. Morcos SK, Thomsen HS European Society of Urogenital Radiology. European Society of Urogenital Radiology guidelines on administering contrast media. Abdom Imaging 2003 28 : 187 190.
7. Toprak O, Mueller C. Differing definitions of contrast induced nephropathy. Swiss Med Wkly 2005 135 : 630.
8. Harjai KJ, Raizada A, Shenoy C, et al. A comparison of contemporary definitions of contrast nephropathy in patients undergoing percutaneous coronary intervention and a proposal for a novel nephropathy grading system. Am J Cardiol 2008 101 : 812 819.
9. Heyman SN, Rosenberger C, Rosen S. Regional alterations in renal haemodynamics and oxygenation: a role in contrast medium-induced nephropathy. Nephrol Dial Transplant 2005 20 (Suppl 1 i6 11.
10. Tumlin J, Stacul F, Adam A, et al. Pathophysiology of contrast induced nephropathy. Am J Cardiol 2006 98 : 14K 20K.
11. Bartorelli AL, Marenzi G. Contrast-induced nephropathy. J Interv Cardiol 2008 21 : 74 85.
12. Heyman SN, Rosen S, Rosenberger C. Renal parenchymal hypoxia, hypoxia adaptation, and the pathogenesis of radiocontrast nephropathy. Clin J Am Soc Nephrol 2008 3 : 288 296.
13. Toprak O. Risk markers for contrast-induced nephropathy. Am J Med Sci 2007 334 : 283 290.
14. Mehran R, Aymong ED, Nikolsky E, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol 2004 44 : 1393 1399.
15. La Manna G, Pancaldi I, Dalmastri V, et al. Post-coronarography application of continuous veno-venous haemofiltration in the prevention of contrast nephropathy in patients with complex multisystem deficiency. In Vivo 2008 22 : 123 129.
16. Meschi M, Detrenis S, Savazzi G. Contrast-induced nephropathy. Current concepts and propositions for Italian guidelines. Recenti Prog Med 2008 99 : 155 162.
17. Feldkamp T, Kribben A. Contrast media induced nephropathy: definition, incidence, outcome, pathophysiology, risk factors and prevention. Minerva Med 2008 99 : 177 196.
18. Weisbord SD, Palevsky PM. Prevention of contrast-induced nephropathy with volume expansion. Clin J Am Nephrol 2008 3 : 273 280.
19. Iakovou I, Dangas G, Mehran R, et al. Impact of gender on the incidence and outcome of contrast induced nephropathy after percutaneous coronary interventions. J Invasive Cardiol 2003 15 : 18 22.
20. Marenzi G, Assanelli E, Marana I, et al. N-acetylcysteine and contrast-induced nephropathy in primary angioplasty. N Engl J Med 2006 354 : 2773 2782.
21. Dangas G, Iakovou I, Nikolsky E, et al. Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables. Am J Cardiol 2005 95 : 13 9.
22. Pucelikova T, Dangas G, Mehran R. Contrast-induced nephropathy. Catheter Cardiovasc Interv 2008 71 : 62 72.
23. Toprak O, Cirit M, Esi E, Postaci N, Yesil M, Bayata S. Hyperuricemia as a risk factor for contrast-induced nephropathy in patients with chronic kidney disease. Catheter Cardiovasc Interv 2006 67 : 227 235. (Pubitemid 43235154)
24. Rich MW, Crecelius CA. Incidence, risk factors, and clinical course of acute renal insufficiency after cardiac catheterization in patients 70 years of age or older: a prospective study. Arch Intern Med 1990 150 : 1237 1242.
25. Nikolsky E, Mehran R, Lasic Z, et al. Low hematocrit predicts contrast-induced nephropathy after percutaneous coronary interventions. Kidney Int 2005 67 : 706 713. (Pubitemid 40139864)